- Company Directors - G
- Gelbman Ronald G
Insider Trading History of Gelbman Ronald G
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Gelbman Ronald G since 2006.
The trader's CIK number is 1210616.
At the time of the last reporting, Gelbman Ronald G was the Director of Haemonetics Corp. (stock ticker symbol HAE).
Also see all insider trading activities at Haemonetics Corp.
Note that in the past
GELBMAN RONALD G also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Serologicals Corp (SERO) by Gelbman Ronald G
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | SERO | 0 | $0 | 1,725 | $42,297 | 4,685 | $52,940 |
Yearly summary of insider trading at Haemonetics Corp (HAE) by Gelbman Ronald G
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | HAE | 0 | $0 | 26,818 | $2,938,303 | 25,122 | $983,184 |
| 2018 | HAE | 0 | $0 | 4,329 | $445,973 | 0 | $0 |
| 2017 | HAE | 0 | $0 | 14,020 | $651,550 | 15,698 | $478,613 |
| 2016 | HAE | 0 | $0 | 5,683 | $229,024 | 11,758 | $349,447 |
| 2015 | HAE | 0 | $0 | 7,707 | $344,934 | 11,328 | $331,117 |
| 2014 | HAE | 0 | $0 | 21,184 | $746,299 | 21,184 | $385,868 |
| 2012 | HAE | 0 | $0 | 19,783 | $1,061,397 | 36,000 | $910,296 |
| 2010 | HAE | 0 | $0 | 15,000 | $898,520 | 15,000 | $398,214 |
| 2009 | HAE | 0 | $0 | 6,000 | $334,698 | 6,000 | $164,064 |
| 2006 | HAE | 4,442 | $199,867 | 0 | $0 | 0 | $0 |
Insider trading activities at 2 companies by Gelbman Ronald G:
1. Serologicals Corp (SERO)
2. Haemonetics Corp (HAE)
Table 1. Insider trading of Serologicals Corp (SERO) by Gelbman Ronald G
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-03-13 | SERO | Option Ex | 4,685 | 11.30 | 52,940 |
| 2006-03-13 | SERO | Sale | 1,725 | 24.52 | 42,297 |
Table 2. Insider trading of Haemonetics Corp (HAE) by Gelbman Ronald G
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-11-11 | HAE | Option Ex | 16,926 | 40.48 | 685,096 |
| 2019-11-11 | HAE | Sale | 16,926 | 118.26 | 2,001,668 |
| 2019-08-08 | HAE | Sale | 1,696 | 134.15 | 227,518 |
| 2019-02-15 | HAE | Sale | 8,196 | 86.52 | 709,117 |
| 2019-02-15 | HAE | Option Ex | 8,196 | 36.37 | 298,088 |
| 2018-12-14 | HAE | Sale | 4,329 | 103.02 | 445,973 |
| 2017-11-16 | HAE | Option Ex | 7,118 | 34.41 | 244,894 |
| 2017-11-16 | HAE | Sale | 5,440 | 56.68 | 308,350 |
| 2017-03-24 | HAE | Sale | 8,580 | 40.00 | 343,200 |
| 2017-03-24 | HAE | Option Ex | 8,580 | 27.24 | 233,719 |
| 2016-12-12 | HAE | Sale | 5,683 | 40.30 | 229,024 |
| 2016-07-29 | HAE | Option Ex | 11,758 | 29.72 | 349,447 |
| 2015-03-05 | HAE | Option Ex | 11,328 | 29.23 | 331,117 |
| 2015-03-05 | HAE | Sale | 7,707 | 44.76 | 344,934 |
| 2014-06-12 | HAE | Sale | 9,184 | 34.00 | 312,283 |
| 2014-06-12 | HAE | Option Ex | 9,184 | 24.96 | 229,232 |
| 2014-03-06 | HAE | Option Ex | 12,000 | 13.05 | 156,636 |
| 2014-03-06 | HAE | Sale | 12,000 | 36.17 | 434,016 |
| 2012-12-13 | HAE | Sale | 11,310 | 40.07 | 453,203 |
| 2012-12-13 | HAE | Option Ex | 24,000 | 18.83 | 451,896 |
| 2012-08-23 | HAE | Sale | 6,000 | 71.90 | 431,400 |
| 2012-08-23 | HAE | Option Ex | 6,000 | 44.74 | 268,440 |
| 2012-05-17 | HAE | Sale | 2,473 | 71.49 | 176,794 |
| 2012-04-23 | HAE | Option Ex | 6,000 | 31.66 | 189,960 |
| 2010-12-23 | HAE | Sale | 6,000 | 64.22 | 385,349 |
| 2010-12-23 | HAE | Option Ex | 6,000 | 32.01 | 192,060 |
| 2010-05-11 | HAE | Sale | 9,000 | 57.02 | 513,171 |
| 2010-04-27 | HAE | Option Ex | 9,000 | 22.91 | 206,154 |
| 2009-09-18 | HAE | Option Ex | 6,000 | 27.34 | 164,064 |
| 2009-09-18 | HAE | Sale | 6,000 | 55.78 | 334,698 |
| 2006-08-02 | HAE | Buy | 4,442 | 44.99 | 199,867 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Gelbman Ronald G
(Director of Haemonetics Corp at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.